LPM682000012
/ Lepu Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 21, 2026
Phase I clinical study of multiple doses of LPM682000012 tablets in healthy subjects
(chinadrugtrials.org.cn)
- P1 | N=0 | Not yet recruiting | Sponsor: Shandong Luye Pharmaceutical Co., Ltd.
New P1 trial • CNS Disorders • Depression • Mood Disorders • Psychiatry
1 to 1
Of
1
Go to page
1